Pilot Evaluation of a New Computerized Test for Pragmatic Inferences in Children with ASD
TIPI
1 other identifier
interventional
232
1 country
1
Brief Summary
This study aims to evaluate the relevance of a new computerized test for pragmatic inferences (TIPi) in children aged 8 to 12 YO, presenting a typical development, autism spectrum disorders, another neurodevelopmental condition and attention-deficit/hyperactivity disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2020
CompletedFirst Posted
Study publicly available on registry
January 28, 2020
CompletedStudy Start
First participant enrolled
February 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 4, 2023
CompletedOctober 28, 2024
November 1, 2023
Same day
January 17, 2020
October 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to TD children in the composite score of the TIPi.
The dissociation between the developmental trajectories of these two groups will be assessed by comparing the coefficients of the linear regressions linking performance in the TIPi (composite score) and chronological age in these two groups.
One day
Secondary Outcomes (3)
Sensitivity of the TIPi composite score (measuring pragmatic inferencing) to typical development in the targeted age range: 8 to 12 years oldin the targeted age range: 8 to 12 years old
One day
The TIPi composite score provides additional information compared to other cognitive assessments typically provided in the global assessment of children with ASD
One day
Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to children with DLD in the composite score of the TIPi.
One day
Study Arms (4)
Children with Autism Spectrum Disorders
EXPERIMENTALA group of 25 children with autism spectrum disorders (ASD)
Typically Developing children
ACTIVE COMPARATORA larger group of 150 typically developing children (TD)
Children with Developmental Language Disorders
EXPERIMENTALA group of 25 children with developmental language disorders (DLD)
children with attention-deficit/hyperactivity disorder (ADHD group)
EXPERIMENTAL25 children with attention-deficit/hyperactivity disorder (ADHD group)
Interventions
Computerized tests
Eligibility Criteria
You may qualify if:
- Age between 8 and 12 years old
- Native French speaker
- Informed consent of the parents and children
- \[For ASD group\] Diagnosis of ASD provided by a trained and entitled clinician
- \[For DLD group\] Diagnosis of DLD provided by a trained and entitled clinician
- \[For ASD and DLD groups\] IQ above 70
- Intellectual efficiency within the norm (ITQ \> 70), confirmed by objective results (psychometrics) in the participant's file, or collected if necessary within the framework of this study (using the WISC V);
- Medical diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) by a competent professional, confirmed by a parental assessment (ADHD-RS-IV)
You may not qualify if:
- Uncorrected visual impairment
- Uncorrected auditory impairment
- Motor disability preventing the use of a touch pad
- \[For the TD group\] Diagnosis of any neurodevelopmental or psychiatric condition
- \[For ASD group\] Diagnosis of language disorder of attention disorder (ADHD)
- \[For DLD group\] Diagnosis of ASD or ADHD
- \[For ADHD group\] Diagnosis of ASD or DLD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ch Le Vinatier
Bron, 69678, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2020
First Posted
January 28, 2020
Study Start
February 7, 2020
Primary Completion
February 7, 2020
Study Completion
May 4, 2023
Last Updated
October 28, 2024
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share